Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
First Clinical Trial Exploring Effects of a New, Immune System-Based Agent in Advanced Melanoma

First Clinical Trial Exploring Effects of a New, Immune System-Based Agent in Advanced Melanoma

Researchers at the University of Pennsylvania School of Medicine and Immunocore Limited, Oxford, UK, today announced that a targeted agent that may have a role in treating advanced metastatic melanoma in the future has received Investigational New Drug (IND) approval and is opening enrollment for clinical trials in the UK and USA.

Karen Kreeger

At the Crossroads of Chromosomes: Penn Study Reveals Structure of Cell Division’s Key Molecule

At the Crossroads of Chromosomes: Penn Study Reveals Structure of Cell Division’s Key Molecule

PHILADELPHIA – On average, one hundred billion cells in the human body divide over the course of a day. Most of the time the body gets it right but sometimes, problems in cell replication can lead to abnormalities in chromosomes resulting in many types of disorders, from cancer to Down Syndrome.

Why the Biological Clock? Penn Study Says Aging Reduces Centromere Cohesion, Disrupts Reproduction

Why the Biological Clock? Penn Study Says Aging Reduces Centromere Cohesion, Disrupts Reproduction

PHILADELPHIA –- University of Pennsylvania biologists studying human reproduction have identified what is likely the major contributing factor to the maternal age-associated increase in aneuploidy, the term for an abnormal number of chromosomes during reproductive cell division.

Jordan Reese